Literature DB >> 9255387

Quantitative analysis of tau protein-immunoreactive accumulations and beta amyloid protein deposits in the cerebral cortex of the mouse lemur, Microcebus murinus.

P Giannakopoulos1, S Silhol, V Jallageas, J Mallet, N Bons, C Bouras, P Delaère.   

Abstract

Recent studies have revealed the presence of tau protein-immunoreactive accumulations and beta amyloid protein (A beta) deposits in the cerebral cortex of the aged mouse lemur, Microcebus murinus. To examine the age-related evolution of these changes and compare their regional distribution to that reported for humans and nonhuman primates with Alzheimer's disease lesions, we performed a quantitative analysis of a large series of mouse lemurs aged from 1 to 13 years. The prevalence and density of tau protein-immunoreactive accumulations in the neocortex of this prosimian increased steadily with age. Neocortical areas were frequently affected even in young mouse lemurs, whereas the subiculum and entorhinal cortex were only involved occasionally in animals older than 8 years. As in anthropoid primates, diffuse A beta deposits were often observed in the cerebral cortex and amygdala of old mouse lemurs. Although all animals with diffuse A beta deposits had tau protein-immunoreactive accumulations in the neocortex, no correlation was found between the densities of these lesions in each area and among the areas studied. The age-dependent progression of tau protein-immunoreactive accumulations indicates that this prosimian may represent a valuable model for the study of the biochemical mechanisms of brain aging, while the relative sparing of hippocampus in mouse lemurs contrasts sharply with previous reports on neurofibrillary tangle formation in humans, and suggests that this animal may also be useful to investigate the biological characteristics of neuroprotection in this area. Furthermore, the present data indicate that A beta deposition in mouse lemurs is not age dependent, but occurs in a few vulnerable old animals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9255387     DOI: 10.1007/s004010050684

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  20 in total

1.  Age-related cerebral atrophy in nonhuman primates predicts cognitive impairments.

Authors:  Jean-Luc Picq; Fabienne Aujard; Andreas Volk; Marc Dhenain
Journal:  Neurobiol Aging       Date:  2010-10-22       Impact factor: 4.673

Review 2.  Alzheimer's disease: experimental models and reality.

Authors:  Eleanor Drummond; Thomas Wisniewski
Journal:  Acta Neuropathol       Date:  2016-12-26       Impact factor: 17.088

Review 3.  Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies.

Authors:  Einar M Sigurdsson
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

4.  Antibody response and plasma Abeta1-40 levels in young Microcebus murinus primates immunized with Abeta1-42 and its derivatives.

Authors:  Stéphanie G Trouche; Ayodeji Asuni; Sylvie Rouland; Thomas Wisniewski; Blas Frangione; Jean-Michel Verdier; Einar M Sigurdsson; Nadine Mestre-Francés
Journal:  Vaccine       Date:  2008-12-27       Impact factor: 3.641

5.  Exogenous LRRK2G2019S induces parkinsonian-like pathology in a nonhuman primate.

Authors:  Nadine Mestre-Francés; Nicolas Serratrice; Aurélie Gennetier; Gina Devau; Sandra Cobo; Stéphanie G Trouche; Pascaline Fontès; Charleine Zussy; Philippe De Deurwaerdere; Sara Salinas; Franck Jd Mennechet; Julien Dusonchet; Bernard L Schneider; Isabella Saggio; Vasiliki Kalatzis; M Rosario Luquin-Piudo; Jean-Michel Verdier; Eric J Kremer
Journal:  JCI Insight       Date:  2018-07-26

6.  AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease.

Authors:  Abraham Fisher; Rachel Brandeis; Rachel Haring Nira Bar-Ner; Michal Kliger-Spatz; Niva Natan; Hagar Sonego; Itzhak Marcovitch; Zipora Pittel
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

Review 7.  Comparative neuropathology in aging primates: A perspective.

Authors:  Carmen Freire-Cobo; Melissa K Edler; Merina Varghese; Emily Munger; Jessie Laffey; Sophia Raia; Selena S In; Bridget Wicinski; Maria Medalla; Sylvia E Perez; Elliott J Mufson; Joseph M Erwin; Elaine E Guevara; Chet C Sherwood; Jennifer I Luebke; Agnès Lacreuse; Mary A Raghanti; Patrick R Hof
Journal:  Am J Primatol       Date:  2021-07-13       Impact factor: 2.371

8.  Micro-MRI study of cerebral aging: ex vivo detection of hippocampal subfield reorganization, microhemorrhages and amyloid plaques in mouse lemur primates.

Authors:  Anne Bertrand; Adrien Pasquier; Alexandra Petiet; Christopher Wiggins; Audrey Kraska; Nelly Joseph-Mathurin; Fabienne Aujard; Nadine Mestre-Francés; Marc Dhenain
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

9.  Using animal models to determine the significance of complement activation in Alzheimer's disease.

Authors:  David A Loeffler
Journal:  J Neuroinflammation       Date:  2004-10-12       Impact factor: 8.322

Review 10.  Precocious Alterations of Brain Oscillatory Activity in Alzheimer's Disease: A Window of Opportunity for Early Diagnosis and Treatment.

Authors:  Valentine Hamm; Céline Héraud; Jean-Christophe Cassel; Chantal Mathis; Romain Goutagny
Journal:  Front Cell Neurosci       Date:  2015-12-21       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.